Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 35.66B | 33.53B | 36.84B | 33.45B | 30.51B |
Gross Profit | 10.82B | 9.93B | 10.96B | 10.28B | 9.10B |
EBITDA | 6.76B | 6.31B | 6.60B | 6.09B | 5.09B |
Net Income | 3.87B | 3.33B | 4.08B | 3.47B | 2.76B |
Balance Sheet | |||||
Total Assets | 59.80B | 59.45B | 56.67B | 54.81B | 53.27B |
Cash, Cash Equivalents and Short-Term Investments | 14.30B | 12.86B | 8.94B | 12.86B | 14.37B |
Total Debt | 1.10B | 27.65M | 35.66M | 16.32M | 15.01M |
Total Liabilities | 10.73B | 11.89B | 10.57B | 10.25B | 10.42B |
Stockholders Equity | 48.16B | 46.65B | 45.27B | 43.73B | 42.12B |
Cash Flow | |||||
Free Cash Flow | 1.75B | 5.01B | -1.32B | -542.08M | 1.96B |
Operating Cash Flow | 4.09B | 6.28B | 1.44B | 2.29B | 4.70B |
Investing Cash Flow | -1.77B | -634.16M | -1.78B | -2.74B | -2.42B |
Financing Cash Flow | -602.16M | -2.55B | -3.32B | -1.40B | -874.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥67.06B | 15.53 | 2.62% | 5.45% | 25.48% | ||
62 Neutral | S$945.00M | 7.19 | -2.49% | 4.55% | 8.79% | 68.42% | |
― | $315.77M | 11.48 | 7.92% | 4.65% | ― | ― | |
― | $353.02M | 13.38 | 6.67% | ― | ― | ― | |
― | €378.36M | 13.11 | 9.65% | ― | ― | ― | |
81 Outperform | ¥54.34B | 11.79 | 3.28% | 8.13% | 5.35% | ||
61 Neutral | ¥46.48B | 17.78 | 1.83% | -2.91% | ― |
Nippon Fine Chemical Co., Ltd. announced the acquisition of 208,100 treasury shares at a cost of JPY 533,285,992, as part of a broader plan approved by its Board of Directors to acquire up to 1,200,000 shares. This strategic move, executed through market purchases on the Tokyo Stock Exchange, aims to optimize the company’s capital structure and potentially enhance shareholder value.
Nippon Fine Chemical Co., Ltd. reported a slight decrease in net sales for the three months ending June 30, 2025, compared to the previous year. Despite this, the company saw significant increases in operating profit, ordinary profit, and profit attributable to owners, reflecting a strong operational performance. The company also announced a forecasted increase in annual dividends per share for the fiscal year ending March 31, 2026, indicating confidence in its financial stability and future growth prospects.
Nippon Fine Chemical Co., Ltd. has completed the payment procedures for the disposal of 9,700 treasury shares as part of a restricted share-based remuneration plan. This move, resolved by the Board of Directors, involves a total disposal value of ¥23,425,500 and is aimed at aligning the interests of directors and corporate officers with the company’s performance.
Nippon Fine Chemical Co., Ltd. has announced the acquisition of 165,400 treasury shares, amounting to JPY 378,534,791, as part of a broader plan to purchase up to 1,200,000 shares by April 2026. This move, conducted through market purchases on the Tokyo Stock Exchange, is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
Nippon Fine Chemical Co., Ltd. has announced a resolution to dispose of 9,700 treasury shares as part of a restricted share-based remuneration plan. This initiative aims to align the interests of directors and corporate officers with shareholders and incentivize the enhancement of the company’s corporate value over the medium to long term.
Nippon Fine Chemical Co., Ltd. announced the acquisition of 260,600 treasury shares at a total cost of JPY 566,631,291, as part of a resolution to acquire up to 1,200,000 shares by April 2026. This move is part of a strategic decision to manage its capital structure and potentially enhance shareholder value.
Nippon Fine Chemical Co., Ltd. announced its opposition to a shareholder proposal from Nippon Active Value Fund plc, which included the purchase of treasury shares, amendments to the articles of incorporation regarding the number of outside directors, and approval of remuneration for a share-based plan. The company’s board of directors believes that their current strategy, which includes purchasing treasury shares and investing in a new plant for functional esters, aligns better with their medium-term management plan and goals for sustainable growth and shareholder returns. The company is focused on maintaining financial stability while balancing growth investments and shareholder returns, with a target to reduce cross-shareholdings and improve capital efficiency.